We evaluated bowel, urinary and sexual function and quality of life using three validated questionnaires in patients treated for rectal cancer. This group was compared to patients undergoing abdominal surgery without pelvic dissection for colon cancer during the same time period.
The response rate was 57 % (381/667) with a median time interval of 4.4 years. A subset of rectal patients documented persistent problems with faecal leakage (16 % ); requiring to alter daily activities (18 % ); always needing to wear a protective pad (17 % ); rarely or never emptying their bowels fully (31 % ); difficulty controlling the passage of gas (32 % ) and requiring to modify diet (30 % ). Altered bowel function was found to impact on overall quality of life. Men reported increased erectile function difficulties. Pre-operative radiotherapy was associated with increased defecation problems as was low level of anastomosis (¡Ü6?cm).
In keeping with emergent evidence, this study has quantified the extent of late adverse effects with a sub-set of rectal cancer patients reporting persistent bowel function problems. The implications are now to consider current follow-up services and to ¡®trial¡¯ new models of comprehensive assessment and interventions in patients who are ¡®at risk¡¯ of experiencing late adverse effects of treatment.